{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:15:01Z","timestamp":1758809701439},"reference-count":25,"publisher":"Elsevier BV","issue":"19-20","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.lfs.2008.02.012","type":"journal-article","created":{"date-parts":[[2008,4,9]],"date-time":"2008-04-09T13:20:35Z","timestamp":1207747235000},"page":"991-996","source":"Crossref","is-referenced-by-count":24,"title":["Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK\/STAT pathway"],"prefix":"10.1016","volume":"82","author":[{"given":"Juan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20133","key":"10.1016\/j.lfs.2008.02.012_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.regpep.2004.04.004","article-title":"Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy","volume":"120","author":"Baker","year":"2004","journal-title":"Regulatory Peptides"},{"issue":"2","key":"10.1016\/j.lfs.2008.02.012_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molmed.2006.12.002","article-title":"Role of the JAK\u2013STAT pathway in myocardial injury","volume":"13","author":"Barry","year":"2007","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.lfs.2008.02.012_bib3","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1006\/jmcc.2002.2076","article-title":"Interplay between the cardiac renin angiotensin system and JAK\u2013STAT signaling: role in cardiac hypertrophy, ischemia\/reperfusion dysfunction, and heart failure","volume":"11","author":"Booz","year":"2002","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"12","key":"10.1016\/j.lfs.2008.02.012_bib4","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/01.CIR.0000034024.61382.42","article-title":"Cardiotrophin-1 in heart failure","volume":"106","author":"Bristow","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lfs.2008.02.012_bib5","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/hc3001.092039","article-title":"Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor","volume":"104","author":"Dechend","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.lfs.2008.02.012_bib6","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.HYP.35.6.1191","article-title":"Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3: an autocrine loop for hypertrophy","volume":"35","author":"Fukuzawa","year":"2000","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.lfs.2008.02.012_bib7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbadis.2007.02.007","article-title":"Involvement of transient receptor potential proteins in cardiac hypertrophy","volume":"1172","author":"Guinamard","year":"2007","journal-title":"Biochimica et Biophysica Acta. Molecular Basis of Disease"},{"issue":"2","key":"10.1016\/j.lfs.2008.02.012_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0021-9150(03)00301-0","article-title":"All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells","volume":"170","author":"Kaneta","year":"2003","journal-title":"Atherosclerosis"},{"issue":"31","key":"10.1016\/j.lfs.2008.02.012_bib9","doi-asserted-by":"crossref","first-page":"21926","DOI":"10.1074\/jbc.274.31.21926","article-title":"3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1)","volume":"274","author":"Laufs","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/j.lfs.2008.02.012_bib10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1440-1681.1999.03165.x","article-title":"Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis","volume":"26","author":"Luo","year":"1999","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"issue":"1","key":"10.1016\/j.lfs.2008.02.012_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjp.0703792","article-title":"Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes","volume":"132","author":"Luo","year":"2001","journal-title":"British Journal of Pharmacology"},{"issue":"14","key":"10.1016\/j.lfs.2008.02.012_bib12","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.lfs.2006.04.005","article-title":"HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1","volume":"79","author":"Morikawa-Futamatsu","year":"2006","journal-title":"Life Sciences"},{"issue":"8","key":"10.1016\/j.lfs.2008.02.012_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1253\/jcj.64.595","article-title":"G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II","volume":"64","author":"Nozato","year":"2000","journal-title":"Japanese Circulation Journal"},{"issue":"2","key":"10.1016\/j.lfs.2008.02.012_bib14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cardiores.2004.10.021","article-title":"STAT3 mediates cardioprotection against ischemia\/reperfusion injury through metallothionein induction in the heart","volume":"65","author":"Oshima","year":"2005","journal-title":"Cardiovascular Research"},{"issue":"1","key":"10.1016\/j.lfs.2008.02.012_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cardiores.2007.03.003","article-title":"The acute phase protein alpha2-macroglobulin induces rat ventricular cardiomyocyte hypertrophy via ERK1,2 and PI3-kinase\/Akt pathways","volume":"75","author":"Padmasekar","year":"2007","journal-title":"Cardiovascular Research"},{"issue":"3","key":"10.1016\/j.lfs.2008.02.012_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/hc2801.094031","article-title":"Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy","volume":"104","author":"Patel","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.lfs.2008.02.012_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/FJC.0b013e3180a72606","article-title":"Simvastatin reverses target organ damage and oxidative stress in angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine","volume":"50","author":"Rugale","year":"2007","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"4","key":"10.1016\/j.lfs.2008.02.012_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/01.hco.0000231401.87232.71","article-title":"The role of statins in endothelial dysfunction in hypertension","volume":"21","author":"Sarkar","year":"2006","journal-title":"Current Opinion in Cardiology"},{"issue":"8934","key":"10.1016\/j.lfs.2008.02.012_bib19","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","author":"Scandinavian Simvastatin Survival Study Group","year":"1994","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.lfs.2008.02.012_bib20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pharmthera.2007.04.010","article-title":"Role of diacylglycerol kinase in cellular regulatory processes: a new regulator for cardiomyocyte hypertrophy","volume":"115","author":"Takeishi","year":"2007","journal-title":"Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/j.lfs.2008.02.012_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1160\/TH05-01-0067","article-title":"Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia","volume":"94","author":"Undas","year":"2005","journal-title":"Thrombosis and Haemostasis"},{"issue":"2","key":"10.1016\/j.lfs.2008.02.012_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.yjmcc.2006.05.006","article-title":"Global changes in gene expression during cardiac hypertrophy: a new direction of cardiac signaling research","volume":"41","author":"Usui","year":"2006","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"1","key":"10.1016\/j.lfs.2008.02.012_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.amjcard.2006.01.066","article-title":"What the statin trials have taught us","volume":"98","author":"Waters","year":"2006","journal-title":"The American Journal of Cardiology"},{"issue":"1\u20132","key":"10.1016\/j.lfs.2008.02.012_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11010-005-9014-5","article-title":"Simvastatin attenuates hypertrophic responses induced by cardiotrophin-1 via JAK\u2013STAT pathway in cultured cardiomyocytes","volume":"284","author":"Wu","year":"2006","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"1","key":"10.1016\/j.lfs.2008.02.012_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2613.2000.00139.x","article-title":"Cytokines and their receptors in cardiovascular diseases-role of gp130 signaling pathway in cardiac myocyte growth and maintenance","volume":"81","author":"Yamauchi-Takihara","year":"2000","journal-title":"International Journal of Experimental Pathology"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320508000957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320508000957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T01:37:41Z","timestamp":1557452261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320508000957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":25,"journal-issue":{"issue":"19-20","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0024320508000957"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2008.02.012","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}